Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obesity
  Free Subscription

Articles published in
Metabolism
    May 2024
  1. NEDELCUT S, Axer S, Olbers T
    The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review.
    Metabolism. 2024;154:155799.
    >> Share

    April 2024
  2. AWAZAWA M, Matsushita M, Nomura I, Kobayashi N, et al
    Imeglimin improves systemic metabolism by targeting brown adipose tissue and gut microbiota in obese model mice.
    Metabolism. 2024;153:155796.
    >> Share

  3. ROSENDO-SILVA D, Gomes PB, Rodrigues T, Viana S, et al
    Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction.
    Metabolism. 2024;153:155788.
    >> Share

    March 2024
  4. PENDERGRAST LA, Ashcroft SP, Ehrlich AM, Treebak JT, et al
    Metabolic plasticity and obesity-associated changes in diurnal postexercise metabolism in mice.
    Metabolism. 2024 Mar 11:155834. doi: 10.1016/j.metabol.2024.155834.
    >> Share

  5. MENG M, Cao Y, Qiu J, Shan G, et al
    Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner.
    Metabolism. 2024;152:155784.
    >> Share

  6. KOKKINOS A, Tsilingiris D, Simati S, Stefanakis K, et al
    Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study.
    Metabolism. 2024;152:155773.
    >> Share

  7. REGMI P, Young M, Minigo G, Milic N, et al
    Photoperiod and metabolic health: evidence, mechanism, and implications.
    Metabolism. 2024;152:155770.
    >> Share

  8. LAVILLE M, Robert M, Segrestin B
    Barriers to metabolic surgery and how to address them.
    Metabolism. 2024;152:155764.
    >> Share

    February 2024
  9. RACHELLE H, Malak G, Houry P, Marc H, et al
    Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis.
    Metabolism. 2024 Feb 13:155812. doi: 10.1016/j.metabol.2024.155812.
    >> Share

  10. SARABHAI T, Kahl S, Gancheva S, Mastrototaro L, et al
    Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease.
    Metabolism. 2024;151:155762.
    >> Share

  11. SAMARASINGHE SNS, Woods C, Miras AD
    Bariatric Surgery in Women with Polycystic Ovary Syndrome.
    Metabolism. 2024;151:155745.
    >> Share

  12. TSILINGIRIS D, Kokkinos A
    Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond.
    Metabolism. 2024;151:155741.
    >> Share

  13. MURPHY E, Finucane FM
    Addressing uncertainty about the role of structured lifestyle modification for metabolic surgery patients.
    Metabolism. 2024;151:155739.
    >> Share

  14. BAUZA-THORBRUGGE M, Vujicic M, Chanclon B, Palsdottir V, et al
    Adiponectin stimulates Sca1(+)CD34(-)-adipocyte precursor cells associated with hyperplastic expansion and beiging of brown and white adipose tissue.
    Metabolism. 2024;151:155716.
    >> Share

    January 2024
  15. FUKUSHIMA T, Maetani T, Chubachi S, Tanabe N, et al
    Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity.
    Metabolism. 2024;150:155715.
    >> Share

  16. ZIQUBU K, Dludla PV, Mabhida SE, Jack BU, et al
    Brown adipose tissue-derived metabolites and their role in regulating metabolism.
    Metabolism. 2024;150:155709.
    >> Share

    October 2023
  17. STEINBACH E, Masi D, Ribeiro A, Serradas P, et al
    Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation.
    Metabolism. 2023 Oct 24:155712. doi: 10.1016/j.metabol.2023.155712.
    >> Share

  18. KARAKASIS P, Patoulias D, Pamporis K, Stachteas P, et al
    Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials.
    Metabolism. 2023 Oct 16:155710. doi: 10.1016/j.metabol.2023.155710.
    >> Share

  19. TSUKAMOTO S, Suzuki T, Wakui H, Uehara T, et al
    Angiotensin II type 1 receptor-associated protein in immune cells: a possible key factor in the pathogenesis of visceral obesity.
    Metabolism. 2023;149:155706.
    >> Share

  20. ULLAH R, Shen Y, Zhou YD, Fu J, et al
    Perinatal metabolic inflammation in the hypothalamus impairs the development of homeostatic feeding circuitry.
    Metabolism. 2023;147:155677.
    >> Share

    September 2023
  21. KOKKORAKIS M, Katsarou A, Katsiki N, Mantzoros CS, et al
    Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery.
    Metabolism. 2023;148:155689.
    >> Share

  22. CHEN W, Cui W, Wu J, Zheng W, et al
    Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion.
    Metabolism. 2023;146:155641.
    >> Share

    August 2023
  23. POLYZOS SA, Vachliotis ID, Mantzoros CS
    Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
    Metabolism. 2023 Aug 4:155676. doi: 10.1016/j.metabol.2023.155676.
    >> Share

  24. HOFFMANN A, Meir AY, Hagemann T, Czechowski P, et al
    A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial.
    Metabolism. 2023;145:155594.
    >> Share

  25. PARK SH, Helsley RN, Fadhul T, Willoughby JLS, et al
    Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD.
    Metabolism. 2023;145:155591.
    >> Share

    July 2023
  26. FERNANDEZ-SAEZ EM, Losarcos M, Becerril S, Valenti V, et al
    Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
    Metabolism. 2023 Jul 28:155663. doi: 10.1016/j.metabol.2023.155663.
    >> Share

  27. MUTURI HT, Ghadieh HE, Abdolahipour R, Stankus HL, et al
    Loss of CEACAM1 in endothelial cells causes hepatic fibrosis.
    Metabolism. 2023;144:155562.
    >> Share

    June 2023
  28. KOSCHKER AC, Warrings B, Morbach C, Seyfried F, et al
    Effect of bariatric surgery on cardio-psycho-metabolic outcomes in severe obesity: A randomized controlled trial.
    Metabolism. 2023 Jun 30:155655. doi: 10.1016/j.metabol.2023.155655.
    >> Share

  29. JUNG EJ, Sung KW, Bae TH, Kim HY, et al
    The N-degron pathway mediates lipophagy: The chemical modulation of lipophagy in obesity and NAFLD.
    Metabolism. 2023 Jun 27:155644. doi: 10.1016/j.metabol.2023.155644.
    >> Share

  30. AXELROD CL, Dantas WS, Kirwan JP
    Sarcopenic obesity: emerging mechanisms and therapeutic potential.
    Metabolism. 2023 Jun 26:155639. doi: 10.1016/j.metabol.2023.155639.
    >> Share

  31. WEI F, Gu Y, He L, Kapoor A, et al
    HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation.
    Metabolism. 2023;145:155631.
    >> Share

  32. BOUTARI C, Hill MA, Procaccini C, Matarese G, et al
    The key role of inflammation in the pathogenesis and management of obesity and CVD.
    Metabolism. 2023 Jun 9:155627. doi: 10.1016/j.metabol.2023.155627.
    >> Share

  33. OH J, Park C, Kim S, Kim M, et al
    High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity.
    Metabolism. 2023 Jun 9:155629. doi: 10.1016/j.metabol.2023.155629.
    >> Share

  34. DE OLIVEIRA MC, Silveira ALM, de Oliveira ACC, Lana JP, et al
    Eosinophils protect from metabolic alterations triggered by obesity.
    Metabolism. 2023 Jun 7:155613. doi: 10.1016/j.metabol.2023.155613.
    >> Share

  35. LIU B, Zhong Y, Huang D, Yang L, et al
    LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis.
    Metabolism. 2023 Jun 3:155609. doi: 10.1016/j.metabol.2023.155609.
    >> Share

  36. WANG H, Xiong Q, He G, Tang J, et al
    Hepatic IDH2 regulates glycolysis and gluconeogenesis.
    Metabolism. 2023;143:155559.
    >> Share

  37. BARAZZONI R, Cederholm T, Zanetti M, Gortan Cappellari G, et al
    Defining and diagnosing sarcopenia: Is the glass now half full?
    Metabolism. 2023;143:155558.
    >> Share

  38. BRETHVAD AO, Zakariassen HL, Holt J, Lundgren JR, et al
    Increased meal-induced neurotensin response predicts successful maintenance of weight loss - Data from a randomized controlled trial.
    Metabolism. 2023;143:155534.
    >> Share

    May 2023
  39. CAPPELLARI GG, Semolic A, Zanetti M, Vinci P, et al
    Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.
    Metabolism. 2023 May 26:155595. doi: 10.1016/j.metabol.2023.155595.
    >> Share

  40. JAVAID HMA, Ko E, Joo EJ, Kwon SH, et al
    TNFalpha-induced NLRP3 inflammasome mediates adipocyte dysfunction and activates macrophages through adipocyte-derived lipocalin 2.
    Metabolism. 2023;142:155527.
    >> Share

    April 2023
  41. PARK MJ, Choi KM
    Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
    Metabolism. 2023 Apr 29:155577. doi: 10.1016/j.metabol.2023.155577.
    >> Share

  42. GUO X, Hu J, He G, Chen J, et al
    Loss of APOO (MIC26) aggravates obesity-related whitening of brown adipose tissue via PPARalpha-mediated functional interplay between mitochondria and peroxisomes.
    Metabolism. 2023 Apr 21:155564. doi: 10.1016/j.metabol.2023.155564.
    >> Share

  43. CHONG B, Kong G, Shankar K, Chew HSJ, et al
    The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000-2019.
    Metabolism. 2023;141:155402.
    >> Share

  44. REBELOS E, Mari A, Oikonen V, Iida H, et al
    Evaluation of renal glucose uptake with [(18)F]FDG-PET: Methodological advancements and metabolic outcomes.
    Metabolism. 2023;141:155382.
    >> Share

    March 2023
  45. PAPADOPOULOS G, Legaki AI, Georgila K, Vorkas P, et al
    Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Metabolism. 2023 Mar 28:155552. doi: 10.1016/j.metabol.2023.155552.
    >> Share

  46. BIANZANO S, Henrich A, Herich L, Kalsch B, et al
    Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies.
    Metabolism. 2023 Mar 21:155550. doi: 10.1016/j.metabol.2023.155550.
    >> Share

  47. XU H, Yu W, Sun M, Bi Y, et al
    Syntaxin17 contributes to obesity cardiomyopathy through promoting mitochondrial Ca(2+) overload in a Parkin-MCUb-dependent manner.
    Metabolism. 2023 Mar 20:155551. doi: 10.1016/j.metabol.2023.155551.
    >> Share

  48. LUO X, Li Z, Chen L, Zhang X, et al
    Monocarboxylate transporter 1 in the liver modulates high-fat diet-induced obesity and hepatic steatosis in mice.
    Metabolism. 2023 Mar 16:155537. doi: 10.1016/j.metabol.2023.155537.
    >> Share

  49. MARLENE C, Christos MS
    Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy.
    Metabolism. 2023 Mar 2:155531. doi: 10.1016/j.metabol.2023.155531.
    >> Share

    February 2023
  50. MILBANK E, Dragano N, Vidal-Gomez X, Rivas-Limeres V, et al
    Small extracellular vesicle targeting of hypothalamic AMPKalpha1 promotes weight loss in leptin receptor deficient mice.
    Metabolism. 2023;139:155350.
    >> Share

    January 2023
  51. BENEDICTE G, Sara F, Paul L, Laetitia N, et al
    Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort.
    Metabolism. 2023 Jan 30:155412. doi: 10.1016/j.metabol.2023.155412.
    >> Share

  52. AHMED M, Makinen VP, Lumsden A, Boyle T, et al
    Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank.
    Metabolism. 2023;138:155342.
    >> Share

  53. DISCHINGER U, Kotzner L, Kovatcheva-Datchary P, Kleinschmidt H, et al
    Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional study.
    Metabolism. 2023;138:155341.
    >> Share

    December 2022
  54. RAJAN S, Hofer P, Christiano A, Stevenson M, et al
    Microsomal triglyceride transfer protein regulates intracellular lipolysis in adipocytes independent of its lipid transfer activity.
    Metabolism. 2022;137:155331.
    >> Share

  55. LARSSON SC, Spyrou N, Mantzoros CS
    Body fatness associations with cancer: evidence from recent epidemiological studies and future directions.
    Metabolism. 2022;137:155326.
    >> Share

    November 2022
  56. XIE H, Wang YH, Liu X, Gao J, et al
    SUMOylation of ERp44 enhances Ero1alpha ER retention contributing to the pathogenesis of obesity and insulin resistance.
    Metabolism. 2022 Nov 22:155351. doi: 10.1016/j.metabol.2022.155351.
    >> Share

  57. ANGELIDI AM, Kokkinos A, Sanoudou D, Connelly MA, et al
    Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
    Metabolism. 2022 Nov 11:155346. doi: 10.1016/j.metabol.2022.155346.
    >> Share

  58. YANG HM, Kim J, Shin D, Kim JY, et al
    Resistin impairs mitochondrial homeostasis via cyclase-associated protein 1-mediated fission, leading to obesity-induced metabolic diseases.
    Metabolism. 2022;138:155343.
    >> Share

  59. HEIANZA Y, Wang X, Rood J, Clish CB, et al
    Changes in circulating bile acid subtypes in response to weight-loss diets are associated with improvements in glycemic status and insulin resistance: The POUNDS Lost trial.
    Metabolism. 2022;136:155312.
    >> Share

    October 2022
  60. DEMARSILIS A, Reddy N, Boutari C, Filippaios A, et al
    Pharmacotherapy of type 2 diabetes: An update and future directions.
    Metabolism. 2022 Oct 11:155332. doi: 10.1016/j.metabol.2022.155332.
    >> Share

    August 2022
  61. CHAO Y, Gao L, Wang X, Cai Y, et al
    Dysregulated adipose tissue expansion and impaired adipogenesis in Prader-Willi syndrome children before obesity-onset.
    Metabolism. 2022 Aug 22:155295. doi: 10.1016/j.metabol.2022.155295.
    >> Share

  62. FERNANDEZ-GARCIA JC, Barrios-Rodriguez R, Asenjo-Plaza M, Ramos-Molina B, et al
    Metformin, testosterone, or both in men with obesity and low testosterone: A double-blind, parallel-group, randomized controlled trial.
    Metabolism. 2022 Aug 16:155290. doi: 10.1016/j.metabol.2022.155290.
    >> Share

  63. SHIN J, Toyoda S, Nishitani S, Onodera T, et al
    SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Metabolism. 2022;133:155236.
    >> Share

    July 2022
  64. CHEN KW, Chen YS, Chen PJ, Yeh SH, et al
    Androgen receptor functions in pericentral hepatocytes to decrease gluconeogenesis and avoid hyperglycemia and obesity in male mice.
    Metabolism. 2022 Jul 29:155269. doi: 10.1016/j.metabol.2022.155269.
    >> Share

    June 2022
  65. DU M, Li X, Xiao F, Fu Y, et al
    Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice.
    Metabolism. 2022 Jun 24:155244. doi: 10.1016/j.metabol.2022.155244.
    >> Share

  66. VALENZUELA-VALLEJO L, Chrysafi P, Bello-Ramos J, Bsata S, et al
    Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity.
    Metabolism. 2022 Jun 11:155237. doi: 10.1016/j.metabol.2022.155237.
    >> Share

    May 2022
  67. BOUTARI C, Mantzoros CS
    A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on.
    Metabolism. 2022 May 15:155217. doi: 10.1016/j.metabol.2022.155217.
    >> Share

  68. CAO C, Koh HE, Van Vliet S, Patterson BW, et al
    Increased plasma fatty acid clearance, not fatty acid concentration, is associated with muscle insulin resistance in people with obesity.
    Metabolism. 2022 May 13:155216. doi: 10.1016/j.metabol.2022.155216.
    >> Share

  69. KIM YJ, Kim HJ, Lee SG, Kim DH, et al
    Aerobic exercise for eight weeks provides protective effects towards liver and cardiometabolic health and adipose tissue remodeling under metabolic stress for one week: A study in mice.
    Metabolism. 2022;130:155178.
    >> Share

  70. SHE QY, Bao JF, Wang HZ, Liang H, et al
    Fibroblast growth factor 21: A "rheostat" for metabolic regulation?
    Metabolism. 2022;130:155166.
    >> Share

  71. ZITTING KM, Vetrivelan R, Yuan RK, Vujovic N, et al
    Chronic circadian disruption on a high-fat diet impairs glucose tolerance.
    Metabolism. 2022;130:155158.
    >> Share

    April 2022
  72. CHENG Y, Han J, Li Q, Shi Y, et al
    Metabolic obesity phenotypes: a friend or foe of digestive polyps?-An observational study based on National Inpatient Database.
    Metabolism. 2022 Apr 12:155201. doi: 10.1016/j.metabol.2022.155201.
    >> Share

  73. UM JH, Park SY, Hur JH, Lee HY, et al
    Bone morphogenic protein 9 is a novel thermogenic hepatokine secreted in response to cold exposure.
    Metabolism. 2022;129:155139.
    >> Share

    March 2022
  74. DU K, Sun L, Luo Z, Cao Y, et al
    Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity.
    Metabolism. 2022 Mar 17:155181. doi: 10.1016/j.metabol.2022.155181.
    >> Share

  75. FRUHBECK G, Becerril S, Martin M, Ramirez B, et al
    High plasma and lingual uroguanylin as potential contributors to changes in food preference after sleeve gastrectomy.
    Metabolism. 2022;128:155119.
    >> Share

  76. KAPLANIAN M, Philippe C, Eid SA, Hackl MT, et al
    Deciphering metformin action in obese mice: A critical re-evaluation of established protocols.
    Metabolism. 2022;128:154956.
    >> Share

    February 2022
  77. SON Y, Choi C, Saha A, Park JH, et al
    REEP6 knockout leads to defective beta-adrenergic signaling in adipocytes and promotes obesity-related metabolic dysfunction.
    Metabolism. 2022 Feb 9:155159. doi: 10.1016/j.metabol.2022.155159.
    >> Share

    January 2022
  78. QU HQ, Qu J, Glessner J, Hakonarson H, et al
    Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients.
    Metabolism. 2022 Jan 28:155156. doi: 10.1016/j.metabol.2022.155156.
    >> Share

  79. PORFLITT-RODRIGUEZ M, Guzman-Arriagada V, Sandoval-Valderrama R, Tam CS, et al
    Effects of aerobic exercise on fibroblast growth factor 21 in overweight and obesity. A systematic review.
    Metabolism. 2022 Jan 14:155137. doi: 10.1016/j.metabol.2022.155137.
    >> Share

  80. GONZALEZ-GARCIA I, Freire-Agulleiro O, Nakaya N, Ortega FJ, et al
    Olfactomedin 2 deficiency protects against diet-induced obesity.
    Metabolism. 2022 Jan 10:155122. doi: 10.1016/j.metabol.2021.155122.
    >> Share

  81. SANOUDOU D, Hill MA, Belanger MJ, Arao K, et al
    Editorial: Obesity, metabolic phenotypes and COVID-19.
    Metabolism. 2022 Jan 10:155121. doi: 10.1016/j.metabol.2021.155121.
    >> Share

  82. LO T, Lee Y, Tseng CY, Hu Y, et al
    Daily transient coating of the intestine leads to weight loss and improved glucose tolerance.
    Metabolism. 2022;126:154917.
    >> Share

  83. TAN EX, Lee JW, Jumat NH, Chan WK, et al
    Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
    Metabolism. 2022;126:154911.
    >> Share

    December 2021
  84. KAUR V, Dimitriadis GK, Perez-Pevida B, Bansi DS, et al
    Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome.
    Metabolism. 2021;125:154908.
    >> Share

    November 2021
  85. HJORTEBJERG R, Bojsen-Moller KN, Soeby M, Oxvig C, et al
    Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4.
    Metabolism. 2021;124:154886.
    >> Share

    September 2021
  86. KOUVARI M, Chrysohoou C, Skoumas J, Pitsavos C, et al
    The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: a population-based cohort study.
    Metabolism. 2021 Sep 30:154893. doi: 10.1016/j.metabol.2021.154893.
    >> Share

  87. KIM NH, Kim KJ, Choi J, Kim SG, et al
    Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity.
    Metabolism. 2021 Sep 30:154894. doi: 10.1016/j.metabol.2021.154894.
    >> Share

  88. PEI Z, Liu Y, Liu S, Jin W, et al
    FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis.
    Metabolism. 2021;122:154840.
    >> Share

    August 2021
  89. ZHU Y, Kim SQ, Zhang Y, Liu Q, et al
    Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake.
    Metabolism. 2021 Aug 6:154861. doi: 10.1016/j.metabol.2021.154861.
    >> Share

  90. LANDRY T, Shookster D, Huang H
    Circulating alpha-klotho regulates metabolism via distinct central and peripheral mechanisms.
    Metabolism. 2021;121:154819.
    >> Share

    July 2021
  91. VAN GALEN KA, Booij J, Schrantee A, Adriaanse SM, et al
    The response to prolonged fasting in hypothalamic serotonin transporter availability is blunted in obesity.
    Metabolism. 2021 Jul 28:154839. doi: 10.1016/j.metabol.2021.154839.
    >> Share

    June 2021
  92. WANG Y, Xu J, Wang Y, Hou H, et al
    Obesity and COVID-19 mortality.
    Metabolism. 2021 Jun 22:154820. doi: 10.1016/j.metabol.2021.154820.
    >> Share

  93. CLEMENTE-OLIVO MP, Habibe JJ, Vos M, Ottenhoff R, et al
    Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity.
    Metabolism. 2021 Jun 10:154815. doi: 10.1016/j.metabol.2021.154815.
    >> Share

  94. PICHE ME, Clavel MA, Auclair A, Rodriguez-Flores M, et al
    Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization.
    Metabolism. 2021;119:154773.
    >> Share

  95. ZHANG Z, Lin T, Meng Y, Hu M, et al
    FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice.
    Metabolism. 2021;119:154767.
    >> Share

    May 2021
  96. FREUER D, Linseisen J, Meisinger C
    Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
    Metabolism. 2021;118:154732.
    >> Share

  97. HARRIS DA, Subramaniam R, Brenner T, Tavakkoli A, et al
    Weight and organ specific immune cell profiling of sleeve gastrectomy in mice.
    Metabolism. 2021;118:154729.
    >> Share

    April 2021
  98. PIETRI L, Giorgi R, Begu A, Lojou M, et al
    Excess body weight is an independent risk factor for severe forms of COVID-19.
    Metabolism. 2021;117:154703.
    >> Share

  99. DU Y, Lv Y, Zha W, Zhou N, et al
    Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis.
    Metabolism. 2021;117:154373.
    >> Share

  100. LIMA VM, Liu J, Brandao BB, Lino CA, et al
    miRNA-22 deletion limits white adipose expansion and activates brown fat to attenuate high-fat diet-induced fat mass accumulation.
    Metabolism. 2021;117:154723.
    >> Share

    February 2021
  101. SANDHU B, Perez Matos MC, Tran S, Singhal G, et al
    Global deletion of NTPDase3 protects against diet-induced obesity by increasing basal energy metabolism.
    Metabolism. 2021 Feb 22:154731. doi: 10.1016/j.metabol.2021.154731.
    >> Share

  102. CHEN SY, Beretta M, Alexopoulos SJ, Shah DP, et al
    Mitochondrial uncoupler SHC517 reverses obesity in mice without affecting food intake.
    Metabolism. 2021 Feb 3:154724. doi: 10.1016/j.metabol.2021.154724.
    >> Share

  103. FAVRE G, Legueult K, Pradier C, Raffaelli C, et al
    Visceral fat is associated to the severity of COVID-19.
    Metabolism. 2021;115:154440.
    >> Share

  104. NAKATSU Y, Yamamotoya T, Okumura M, Ishii T, et al
    Prolyl isomerase Pin1 interacts with adipose triglyceride lipase and negatively controls both its expression and lipolysis.
    Metabolism. 2021;115:154459.
    >> Share

  105. PICHE ME, Tardif I, Auclair A, Poirier P, et al
    Effects of bariatric surgery on lipid-lipoprotein profile.
    Metabolism. 2021;115:154441.
    >> Share

    January 2021
  106. ANGELIDI AM, Kokkinos A, Katechaki E, Ros E, et al
    Mediterranean diet as a nutritional approach for COVID-19.
    Metabolism. 2021;114:154407.
    >> Share

  107. LI K, Zhang K, Wang H, Wu Y, et al
    Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.
    Metabolism. 2021;114:154349.
    >> Share

    December 2020
  108. WU Z, Xi P, Zhang Y, Wang H, et al
    LKB1 up-regulation inhibits hypothalamic inflammation and attenuates diet-induced obesity in mice.
    Metabolism. 2020 Dec 21:154694. doi: 10.1016/j.metabol.2020.154694.
    >> Share

  109. LI L, Spranger L, Soll D, Beer F, et al
    Metabolic impact of weight loss induced reduction of adipose ACE-2 - Potential implication in COVID-19 infections?
    Metabolism. 2020;113:154401.
    >> Share

  110. KIM MN, Lo CH, Corey KE, Liu PH, et al
    Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women.
    Metabolism. 2020;113:154398.
    >> Share

    November 2020
  111. ZENG Q, Wang L, Dong S, Zha X, et al
    CT-derived abdominal adiposity: distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China.
    Metabolism. 2020 Nov 28:154456. doi: 10.1016/j.metabol.2020.154456.
    >> Share

  112. VOIGTMANN F, Wolf P, Landgraf K, Stein R, et al
    Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity.
    Metabolism. 2020 Nov 19:154438. doi: 10.1016/j.metabol.2020.154438.
    >> Share

  113. JI D, Zhang M, Qin E, Zhang L, et al
    Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19.
    Metabolism. 2020 Nov 18:154437. doi: 10.1016/j.metabol.2020.154437.
    >> Share

  114. RAPOSO HF, Forsythe P, Chausse B, Castelli JZ, et al
    Novel role of cholesteryl ester transfer protein (CETP): attenuation of adiposity by enhancing lipolysis and brown adipose tissue activity.
    Metabolism. 2020 Nov 6:154429. doi: 10.1016/j.metabol.2020.154429.
    >> Share

    October 2020
  115. HILL MA, Sowers JR, Mantzoros CS
    Commentary: COVID-19 and Obesity Pandemics Converge into a Syndemic Requiring Urgent and Multidisciplinary Action.
    Metabolism. 2020 Oct 17:154408. doi: 10.1016/j.metabol.2020.154408.
    >> Share

  116. DENT R, McPherson R, Harper ME
    Factors affecting weight loss variability in obesity.
    Metabolism. 2020 Oct 6:154388. doi: 10.1016/j.metabol.2020.154388.
    >> Share

  117. WATANABE M, Caruso D, Tuccinardi D, Risi R, et al
    Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19.
    Metabolism. 2020;111:154319.
    >> Share

  118. MAJUMDAR A, Tsochatzis EA
    Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
    Metabolism. 2020;111S:154291.
    >> Share

    September 2020
  119. HUANG Y, Yao LU, Huang YM, Wang M, et al
    Obesity in patients with COVID-19: a systematic review and meta-analysis.
    Metabolism. 2020 Sep 28:154378. doi: 10.1016/j.metabol.2020.154378.
    >> Share

  120. MOIN ASM, Sathyapalan T, Atkin SL, Butler AE, et al
    M2 macrophage markers in type 2 diabetes.
    Metabolism. 2020 Sep 16:154374. doi: 10.1016/j.metabol.2020.154374.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016